Ipca Laboratories (Ipca) and US-based Oncobiologics, Inc. have entered into an agreement for creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products.
For Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
0 comments:
Post a Comment